Skip to main content

Table 1 Epidemiologic and clinical data of clinical M. tuberculosis isolates

From: Comparative genomic analysis of Mycobacterium tuberculosis clinical isolates

Isolates

Type

Drug resistance profilesa

Age, years

Gender

Geographic location

Year of isolation

Treatment history

Clinical outcome

24 locus MIRU-VNTR profiles

Mtb562

Susceptible

None

22

Male

Liaoning

2010

New

Cure

223224163533-454334682431

Mtb526

MDR

INH, RMP, STR

39

Male

Shanxi

2011

Retreated

Cure

233224163533-454344672432

Mtb194

Pre-XDR

INH, RMP, STR, EMB, OFX, LVX

21

Female

Beijing

2010

New

Cure

213224163433-243344572422

Mtb293

Pre-XDR

INH, RMP, OFX, LVX, PAS, ETH

35

Female

Heilongjiang

2009

n.a.

n.a.

233324163523-454344682432

Mtb940

Pre-XDR

INH, RMP, STR, EMB, PAS, OFX, LVX, ETH

63

Male

Hebei

2010

New

Cure

233324143533-254344672432

Mtb984

XDR

INH, RMP, STR, EMB, OFX, LVX, KAN

72

Male

Anhui

2011

Retreated

Cure

233424173534-254344482432

Mtb43

XDR

INH, RMP, STR, EMB, PZA, OFX, LVX, KAN, CAP, AMK, PAS, ETH

47

Male

Henan

2009

Retreated

Died

232224153433-454344582432

  1. n.a. = not available.
  2. aINH, isoniazid; RMP, rifampicin; STR, streptomycin; EMB, ethambutol; PZA, pyrazinamide; OFX, ofloxacin; LVX, levofloxacin; KAN, kanamycin; CAP, capreomycin; AMK, amikacin; PAS, para-amino salicylic acid; ETH, ethionamide.